Crucell, Pepscan Therapeutics deal

Crucell will use Pepscan's Chemical Linkage of Peptides onto Scaffolds (CLIPS) technology to develop vaccines to treat undisclosed infectious diseases. CLIPS technology presents one or more linear pep...